Clinical Trials - AGA Medical Corporation

As the leader in the manufacturing of devices for minimally invasive repair of structural heart defects, AGA Medical is performing clinical trials in the United States, Europe, United Kingdom and Canada to evaluate potential treatments for a variety of diagnoses and heart defects. AGA Medical has invested almost $95 million in research and development, including our clinical trial program, in the last three years.

Completed trials have resulted in the availability of treatment options that have changed the standard of care for patients worldwide.

Current Clinical Trials

	Respect Trial - United States AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.
	Premium Trial - United States AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.